Cargando…
Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation
Nanotechnology-based health products are providing innovative solutions in health technologies and the pharmaceutical field, responding to unmet clinical needs. However, suitable standardised methods need to be available for quality and safety assessments of these innovative products prior to their...
Autores principales: | Halamoda-Kenzaoui, B., Vandebriel, R.J., Howarth, A., Siccardi, M., David, C.A.W., Liptrott, N.J., Santin, M., Borgos, S.E., Bremer-Hoffmann, S., Caputo, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390938/ https://www.ncbi.nlm.nih.gov/pubmed/34126169 http://dx.doi.org/10.1016/j.jconrel.2021.06.016 |
Ejemplares similares
-
Main trends of immune effects triggered by nanomedicines in preclinical studies
por: Halamoda-Kenzaoui, Blanka, et al.
Publicado: (2018) -
Future perspectives for advancing regulatory science of nanotechnology-enabled health products
por: Halamoda-Kenzaoui, Blanka, et al.
Publicado: (2022) -
Mapping of the available standards against the regulatory needs for nanomedicines
por: Halamoda‐Kenzaoui, Blanka, et al.
Publicado: (2018) -
Toxic effects of nanomaterials for health applications: How automation can support a systematic review of the literature?
por: Halamoda‐Kenzaoui, Blanka, et al.
Publicado: (2021) -
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
por: Minnema, Jordi, et al.
Publicado: (2022)